Mutations of TP53 gene in adult acute lymphoblastic leukemia at diagnosis do not affect the achievement of hematologic response but correlate with early relapse and very poor survival

التفاصيل البيبلوغرافية
العنوان: Mutations of TP53 gene in adult acute lymphoblastic leukemia at diagnosis do not affect the achievement of hematologic response but correlate with early relapse and very poor survival
المؤلفون: Barbara Peruta, Tamara Intermesoli, Emanuele Angelucci, Elisabetta Terruzzi, Orietta Spinelli, Silvia Salmoiraghi, Alessandro Rambaldi, Manuela Tosi, Pamela Zanghì, Greta Ubiali, Elena Oldani, Irene Cavattoni, Cristina Boschini, Fabio Ciceri, Alexander Kohlmann, Silvia Bungaro, Renato Bassan, Marie Lorena Guinea Montalvo
المساهمون: Salmoiraghi, Silvia, Montalvo, Marie Lorena Guinea, Ubiali, Greta, Tosi, Manuela, Peruta, Barbara, Zanghi, Pamela, Oldani, Elena, Boschini, Cristina, Kohlmann, Alexander, Bungaro, Silvia, Intermesoli, Tamara, Terruzzi, Elisabetta, Angelucci, Emanuele, Cavattoni, Irene, Ciceri, Fabio, Bassan, Renato, Rambaldi, Alessandro, Spinelli, Orietta
المصدر: Haematologica. 101:e245-e248
بيانات النشر: Ferrata Storti Foundation (Haematologica), 2016.
سنة النشر: 2016
مصطلحات موضوعية: Adult, Male, Oncology, medicine.medical_specialty, Survival, Early Relapse, Acute lymphoblastic leukemia, Affect (psychology), medicine.disease_cause, Tp53 mutation, Disease-Free Survival, 03 medical and health sciences, 0302 clinical medicine, hemic and lymphatic diseases, Internal medicine, medicine, Humans, Online Only Articles, Survival rate, Gene, Mutation, business.industry, TP53 mutation, Hematology, Middle Aged, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Hematologic Response, Survival Rate, 030220 oncology & carcinogenesis, Immunology, Adult Acute Lymphoblastic Leukemia, Female, Early relapse, Tumor Suppressor Protein p53, business, Human, 030215 immunology
الوصف: In adult acute lymphoblastic leukemia (ALL) the evaluation of clinical and biological conventional risk criteria at diagnosis is important but not sufficient to predict clinical outcome. The impact of TP53 mutations has been investigated in a limited number of studies and has still not been defined
تدمد: 1592-8721
0390-6078
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36f38e28c2bf2bd6ae8f357cee3c9312
https://doi.org/10.3324/haematol.2015.137059
حقوق: OPEN
رقم الأكسشن: edsair.doi.dedup.....36f38e28c2bf2bd6ae8f357cee3c9312
قاعدة البيانات: OpenAIRE